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Abstract: Background: Visual hallucinations (VH) are a common symptom in dementia with Lewy
bodies (DLB); however, their cognitive underpinnings remain unclear. Hallucinations have been
related to cognitive slowing in DLB and may arise due to impaired sensory input, dysregulation
in top-down influences over perception, or an imbalance between the two, resulting in false visual
inferences. Methods: Here we employed a drift diffusion model yielding estimates of perceptual
encoding time, decision threshold, and drift rate of evidence accumulation to (i) investigate the nature
of DLB-related slowing of responses and (ii) their relationship to visuospatial performance and visual
hallucinations. The EZ drift diffusion model was fitted to mean reaction time (RT), accuracy and
RT variance from two-choice reaction time (CRT) tasks and data were compared between groups of
mild cognitive impairment (MCI-LB) LB patients (n = 49) and healthy older adults (n = 25). Results:
No difference was detected in drift rate between patients and controls, but MCI-LB patients showed
slower non-decision times and boundary separation values than control participants. Furthermore,
non-decision time was negatively correlated with visuospatial performance in MCI-LB, and score on
visual hallucinations inventory. However, only boundary separation was related to clinical incidence
of visual hallucinations. Conclusions: These results suggest that a primary impairment in perceptual
encoding may contribute to the visuospatial performance, however a more cautious response strategy
may be related to visual hallucinations in Lewy body disease. Interestingly, MCI-LB patients showed
no impairment in information processing ability, suggesting that, when perceptual encoding was
successful, patients were able to normally process information, potentially explaining the variability
of hallucination incidence.
Keywords: Lewy body disease; mild cognitive impairment; attention; visual hallucinations;
perception; drift diffusion; vision
1. Introduction
Dementia with Lewy bodies (DLB) is clinically characterized by four core clinical features, frequent
cognitive fluctuations, complex visual hallucinations, rapid eye movement sleep behavior disorder
(RBD), and Parkinsonism [1]. Cognitively, DLB patients also experience disproportionate impairment
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in attention and visual perceptual abilities in comparison to both older adults and patients with
Alzheimer’s disease (AD) [1–4]. The question arises how these cognitive and perceptual impairments
relate to clinical symptoms in DLB. For instance, visual hallucinations may arise from bottom up
visuoperceptual and top-down attentional impairments [5], and similarly, cognitive fluctuations may
be related to attentional deficits [6].
Mild cognitive impairment with Lewy bodies (MCI-LB) refers to individuals experiencing mild
cognitive impairment which is likely to progress to DLB [7]. MCI refers to the stage between normal
aging and dementia, in which cognitive decline occurs, but activities of daily living are relatively
preserved [8]. Patients may be diagnosed with possible MCI-LB if one core clinical feature or
biomarker is present, or patients may be diagnosed with probable MCI-LB if two or more clinical
features are present, or one clinical feature plus one biomarker according to the proposed MCI-LB
criteria [7]. Cognitively, MCI-LB patients experience marked impairments in processing speed,
executive dysfunction and visuospatial functions [3]. A greater slowing of response times (RT) in
DLB compared with AD patients and healthy older controls, particularly in tasks with increasing
complexity of cognitive processing has been frequently reported (i.e., in choice reaction task; CRT) [9,10].
For instance, DLB patients show disproportional slowing in flanker performance, but can exhibit
the flanker effect when alerted to the trial [11]. Moreover, DLB patients exhibit large intraindividual
fluctuation in RT performance, that may underpin cognitive fluctuation [10,12]. However, not all
studies have found variability in CRT performance to be related to visual or attentional performance,
thus this link remains unclear [13]. Currently, the nature of RT slowing and variability in DLB and
their relationship to clinical symptoms is not well understood. To address this, the present study
adopted the diffusion drift model (DDM) to gain a better understanding of the nature of RT slowing in
DLB patients.
Based on the assumptions that decisions occur over time and are prone to errors, the DDM can be
applied to CRTs. The drift diffusion model [14,15] is a sequential-sampling model, which assumes
that information driving a decision is accumulated over time, until it reaches one of two response
boundaries (denoted by “upper” and “lower” response boundaries in Figure 1) and forms the ultimate
response (for example, a “left” or “right” response would be the upper or lower response boundaries
in a model as depicted in Figure 1). According to the diffusion model, overall processing is segmented
into several components that contribute to ultimate performance: (1) first, components of processing
that do not include active decision-making, i.e., such as perceptual encoding and response execution
which are represented by the “non-decision time (t)”, (2) second, a criterion threshold that information
accumulates to, which is represented by the “boundary separation (a)”, and finally, (3) the rate that
information accumulates towards a decision, estimated by the “drift rate (v)”. The DDM assumes that
the accumulation of information (drift rate) during a decision process is not constant but varies over
time, represented by (s). This variability also contributes to error responses, where the accumulation of
information can reach the incorrect boundary. For example, in the context of a flanker task in which
stimuli are either congruent and thus “easy”, or incongruent and thus “harder”, drift rates will tend to
be more prone to variation in harder conditions, and therefore response times are slower and have a
higher probability of reaching an incorrect response boundary.
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Figure 1. The drift diffusion model. Red and blue denote the information being accumulated during 
one trial towards one of two responses in a 2-choice task (for example, left or right). Lines in the center 
of the figure represent the noisy accumulation of evidence for either decision during a trial. In this 
instance, more evidence is accumulated toward a blue (upper) response. Reaction times from each 
trial are fit to this model to return an average estimate of non-decision time (t), boundary separation 
or threshold (a), and drift rate (v). Adapted from Wiecki et al. [16]. 
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increased boundary separation values and lengthening of non-decision times despite no difference 
in accuracy between older and younger adults [17,18]. Drift rate remains relatively preserved in older 
adults, indicating a shift in response strategy to a more cautious decision-making approach. 
The DDM was applied to CRT performance of Parkinson’s (PD) patients with hallucinations 
relative to PD without hallucinations and healthy controls. Slower drift rates were found in PD 
patients with hallucinations, and shorter perceptual encoding times were found in all PD patients 
compared to controls, suggesting that the accumulation of evidence was hindered by perceptual 
encoding problems [19]. The authors proposed that impaired sensory evidence accumulation may 
lead to reduced information processing quality and an over-reliance on top down processing in PD, 
which in turn may underpin visual hallucinations. 
The question arises whether DLB patients share similar impairments in perceptual and evidence 
accumulation as PD patients and whether these can be detected at the MCI-LB stage. By employing 
a variation of the DDM—the EZ model [20] to assess elements of CRT that may indicate a primary 
perceptual or attentional impairment, we may be able to narrow down those cognitive processes that 
underpin visual impairments, cognitive slowing and visual hallucinations in MCI-LB patients. This 
is of importance, as hallucinations in Lewy body disorders have been proposed to be the product of 
impaired sensory input and dysfunctional attentional in terms of faulty top-down attentional control 
[21,22], but the relative contribution of these processes remains unclear. Moreover, visual 
hallucinations are a predictor of cognitive decline in PD and have a significant effect on the quality 
of life and treatment of patients and caregivers in both PD and DLB [23], therefore there is a clear 
clinical need in understanding this symptom. As both DLB and PD patients often experience visual 
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The DDM has been extensively applied in aging research due to the effect of aging on the speed
accuracy trade off. Most consistent findings from drift diffusion modelling in older adults show
increased boundary separation values and lengthening of non-decision times despite no difference in
accuracy between older and younger adults [17,18]. Drift rate remains relatively preserved in older
adults, indicating a shift in response strategy to a more cautious decision-making approach.
The DDM was applied to CRT performance of Parkinson’s (PD) patients with hallucinations
relative to PD without hallucinations and healthy controls. Slower drift rates were found in PD
patients with hallucinations, and shorter perceptual encoding times were found in all PD patients
compared to controls, suggesting that the accumulation of evidence was hindered by perceptual
encoding problems [19]. The authors proposed that impaired sensory evidence accumulation may
lead to reduced information processing quality and an over-reliance on top down processing in PD,
which in turn may underpin visual hallucinations.
The question arises whether DLB patients share similar impairments in perceptual and evidence
accumulation as PD patients and whether these can be detected at the MCI-LB stage. By employing
a variation of the DDM—the EZ model [20] to assess elements of CRT that may indicate a primary
perceptual or attentional impairment, we may be able to narrow down those cognitive processes that
underpin visual impairments, cognitive slowing and visual hallucinations in MCI-LB patients. This is of
importance, as hallucinations in Lewy body disorders have been proposed to be the product of impaired
sensory input and dysfunctional attentional in terms of faulty top-down attentional control [21,22],
but the relative contribution of these processes remains unclear. Moreover, visual hallucinations
are a predictor of cognitive decline in PD and have a significant effect on the quality of life and
treatment of patients and caregivers in both PD and DLB [23], therefore there is a clear clinical need in
understanding this symptom. As both DLB and PD patients often experience visual hallucinations,
and share pathological features, it was hypothesized that MCI-LB patients would show similar
impairments in drift rate and perceptual encoding times as those previously reported for PD patients
with hallucinations.
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2. Materials and Methods
2.1. Participants
Patients were part of the Lewy-Pro cohort [24]. Participants have been described in detail
previously [24,25]. Briefly, individuals were recruited from memory clinics in the North East of England
and Cumbria, were over 60 years of age and met NIA-AA criteria for MCI. All participants were
clinically assessed for core features of DLB by an experienced psychiatrist (PD). Additional assessments
included neuropsychological assessment and dopaminergic imaging using 123I-N-fluoropropyl-
2β-carbomethoxy-3β-(4-iodophenyl) single-photon emission computed tomography (FP-CIT SPECT),
which were rated normal/abnormal blind to clinical information by an expert panel.
Diagnosis was made by a consensus panel of old age psychiatrists, and participants were
categorized into one of two groups; probable MCI-LB in which patients had two or more of the core
diagnostic features of DLB or one feature and an abnormal FP-CIT scan, and possible MCI-DLB in
which patients had one core feature or an abnormal FP-CIT scan. These diagnoses match the categories
of probable MCI-LB and possible MCI-LB in the recently published international consensus criteria [7].
Patients were excluded if they had dementia, an MMSE score <20, a CDR score of >0.5, Parkinsonism
which developed more than one year prior to cognitive impairment, or evidence of stroke, neurological
or medical conditions which would affect performance in assessments. For this investigation, data from
a subset of 50 participants described previously by Donaghy et al., [24] were accessed, including
CRT data, and clinical assessments. One participant (probable MCI-LB) was excluded due to limited
CRT data.
Healthy controls were recruited from the School of Psychology volunteer’s panel at Cardiff
University, local age interest groups and the Join Dementia Research community in Cardiff, South Wales,
UK. Controls had no visual disturbances, no history of psychiatric illness, no current diagnosis of
dementia or cognitive impairment, and were over the age of 60 years. A group of younger control
participants was also included in the analysis, which allowed us to contrast disease and normal
aging-related differences in the drift diffusion parameters. These participants were recruited from a
School of Psychology undergraduate student database at Cardiff University, and were subject to the
same exclusion criteria as the older control participants. Table 1 shows demographic information of
the cohort.
Table 1. Demographic information of Lewy-Pro cohort and control participants. ACE = Addenbrooke’s
Cognitive Examination, NEVHI = North East Visual Hallucinations Inventory, UPDRS = Unified
Parkinson’s Disease Rating Scale, CAF = Clinical Assessment of Fluctuations.
Probable MCI- LB
(n = 37)
Possible MCI- LB
(n = 12)
Older Controls
(n = 25)
Younger Controls
(n = 25)
Age 72.86 (15.51) 75.25 (7.3) 68.36 (6.11) 21.69 (2.85)
Sex Female = 13 Female = 3 Female = 13 Female = 15
Education 11.57 (2.85) 10.75 (2.09) 15.12 (2.40) 14.95 (1.89)
ACE 78.34 (8.88) 79.33 (14.09) 93.52 (4.18) 92.38 (3.12)
Visual Hallucinations 20 2 - -
NEVHI 3.66 (4.47) 1 (3.316) 0 0
UPDRS 25.21 (15.71) 15.36 (7.75) - -
CAF 2.70 (3.03) 2.16 (2.48) 0.32 (0.63) 0
Cholinesterase Inhibitor 18 0 - -
Levodopa 8 0 - -
2.2. Materials
Lewy-Pro participants’ general cognitive performance was assessed with the Addenbrooke’s
Cognitive Exam (ACE-R; [26], verbal fluency with the FAS Verbal Fluency and Graded Naming
Tests [27], attention-switching with the Trail-making test parts A and B and verbal memory with the
Rey Auditory Verbal learning test (RAVLT) [28]. Participants completed computerized assessments of
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CRT, digit vigilance and visuoperceptual functions, in addition to clinical assessments including the
Geriatric Depression Scale (GDS) [29], Clinician Assessment of Fluctuations [30], Dementia Cognitive
Fluctuations Scale (DCFS) [31], Neuropsychiatric Inventory (NPI) [32], North East Visual Hallucinations
Interview (NEVHI) [33], Unified Parkinson’s Disease Rating Scale (UPDRS) [34], and the Instrumental
Activities of Daily Living scale (ADL) [35]. Control participants were also assessed using a computerized
assessment of choice reaction time, the ACE-R, CAF and NEVHI.
2.3. Procedure
MCI-LB participants completed a simple CRT ‘left or right’ arrow response task (30 trials) as
described in Donaghy et al. [24]. RT data for each control participant were collected using a CRT
flanker task [36]. The task consisted of five horizontal arrows presented on the screen. Participants
were instructed to attend to the central arrow and respond to the direction the target arrow pointed to,
using either left or right arrow keys. Central arrows were flanked either by lines (neutral condition)
or by arrows that either pointed in the same direction as the central arrow (congruent condition) or
in its opposite direction (incongruent condition). Targets were presented on the screen for 1700 ms,
and participants were asked to respond as quickly and as accurately as possible. Participants completed
96 trials in each block, for a duration of 5 blocks, with a rest of 30 s between each block, totaling 480 trials.
For the purposes of the DDM analyses and to account for differences in complexity of tasks between
groups, EZ model parameters for the control participants were calculated only from the RT data of the
“neutral” condition in the CRT flanker task (number trials =160).
The means of RT, accuracy and RT variance were generated for each participant across all
completed trials. Participants were excluded from the analysis if they did not complete the task
(n = 1). A simplified version of the original drift diffusion model, the EZ DDM [20] was then used to
estimate each participants’ drift rate [v], boundary separation [a], and non-decision time [t] from mean
and variance of RTs in correct decision trials and from accuracy (proportion correct). The EZ model
outperforms other DDM in fitting CRT data from limited trial numbers (<100), and thus is particularly
suitable for the modelling of data from patients with reduced cognitive abilities [37]. The EZ model
has also been shown to be sensitive to responses which may arise from sources outside the diffusion
process assumptions [38], although also see Ratcliff et al. for further information [39].
2.4. Statistical Analyses
Group differences in mean RT, accuracy, RT variance, and the three EZ DDM parameters
(non-decision time, boundary separation, and drift rate) were tested between young and older
participants to assess age-related effects, and between older participants and possible MCI-LB and
probable MCI-LB groups respectively, to assess disease-related effects. Variance was assessed using
Levene’s test for homogeneity of variance. Due to the high variance in patient data, non-parametric
Kruskall–Wallis tests, with post-hoc Mann–Whitney U tests were employed for all group comparisons.
All multiplicity of post-hoc testing was corrected with 5% False Discover Rate (FDR) using the
Benjamini–Hochberg procedure [40] where pcor is reported as FDR corrected p-values.
Following this, linear hierarchical stepwise regression models were fit to demographic and DDM
data in order to determine the best predictors of clinical measures in both possible and probable
MCI-LB groups. Spearman rho correlations were calculated between significant predictors and clinical
measures to assess the direction of effects.
Patient groups were also categorized on the basis of their NEVHI score, with a high NEVHI
indicating greater incidence of visual disturbances. This allowed us to compare drift parameters
between those patients who experienced symptoms without visual hallucinations, (NEVHI score = 0;
NEVHI−, n = 29) and those who experienced symptoms with visual hallucinations (NEVHI score > 1;
NEVHI+, n = 20), see [19]. In addition, these comparisons were also conducted between patients with
clinically rated absence (n = 37) or presence (n = 12) of complex visual hallucinations. Mann–Whitney
U tests were used to assess group differences in DDM parameters.
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3. Results
3.1. Demographics
Kruskal–Wallis H tests revealed group differences in age (χ2 (2) = 12.558, p = 0.002) and education
(χ2 (2) = 22.280, <0.001). Both probable and possible MCI-LB groups were significantly older than
healthy control participants (probable: U = 189, pcor < 0.001; possible: U = 65, pcor = 0.02). In addition,
control participants had significantly more years of education than possible (U = 241.5, pcor < 0.001)
and probable MCI-LB groups (U = 661.5, pcor = 0.001).
3.2. Mean RT, Accuracy and Variance Differences between Older Versys Younger Controls and between Older
Controls and MCI-LB Groups
Kruskal–Wallis H tests showed group differences in mean RT (χ2 (2) = 15.747, p < 0.001),
mean accuracy (χ2 (2) = 16.927, p < 0.001), mean RT variance (χ2 (2) = 7.589, p = 0.022) and standard
deviation in RT (χ2 (2) = 26.503, p < 0.001). Younger participants had significantly lower RTs than older
controls (U = 499, pcor < 0.001) (Figure 2A); however, younger and older adults did not significantly
differ in accuracy (p= 0.17) (Figure 2B). Both RT variance (p= 0.25) and RT standard deviation (p= 0.621)
did not differ between younger and older adults.
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Figure 2. (A) Diagnostic group differences in mean reaction time (RT) (B) Group differences in mean
Old = older healthy controls, young = younger healthy controls, Poss. LB = possible MCI-LB, Prob.
LB = probable MCI-LB. (C) Standard deviation of RT is significantly greater in possible and probable
MCI-LB than older adults. ** pcor = 0.01, *** pcor < 0.001.
Mean RTs were significantly lower in the older control relative to the probable MCI-LB group
(U = 157, pcor < 0.001) (Figure 2A). Healthy older controls also had higher accuracy scores than possible
(U = 46, pcor < 0.001) and probable MCI-LB patients (U = 215, pcor < 0.001) (Figure 2B). Reaction time
variance did not differ between healthy older controls and possible MCI-LB (pcor = 0.82), or probable
MCI-LB (pcor = 0.64). Standard deviation was significantly greater in possible MCI-LB (pcor = 0.0015)
and probable MCI-LB (pcor < 0.001) in comparison to healthy older controls.
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3.3. Group Differences in DDM Parameters
Kruskal–Wallis H tests showed significant differences between all groups in non-decision time
(χ2 (2) = 20.429, p < 0.001) and boundary separation values (χ2 (2) = 9.808, p = 0.007), but not drift rates
(χ2 (2) = 0.174, p = 0.917). Post-hoc Mann–Whitney U tests revealed that older adults had significantly
longer boundary separation values than younger adults (U = 415, pcor = 0.04). No significant difference
in non-decision time (p = 0.11) between older and younger adults were observed.
Post-hoc Mann–Whitney U tests showed significantly lower boundary separation values in both
possible MCI-LB (U = 53, pcor = 0.004), and probable MCI-LB (U = 240, pcor = 0.009) in comparison
to older adults. Moreover, greater non-decision times were observed in possible MCI-LB (U = 56,
pcor = 0.005), and probable MCI-LB (U = 125, pcor ≤ 0 0.001) in comparison to older adults. In addition,
no significant differences in boundary separation value (pcor = 0.61) and non-decision time (pcor = 0.40)
were observed between possible and probable MCI-LB. Mann–Whitney U tests also showed significant
differences in variances between drift rate, non-decision time and boundary separation values between
older adults, possible MCI-LB and probable MCI-LB groups (drift: U = 23.5, pcor < 0.001; non-decision:
U = 444, pcor ≤ 0.001; boundary: U = 420, pcor < 0.001). Additionally, Levene’s test of variance showed
significantly greater variation in non-decision time (F (2, 69) = 8.41, p < 0.001), boundary separation
(F (2, 68) = 3.26, p = 0.041), and drift rate (F (2, 71) = 9.809, p < 0.001) between control participants and
the probable MCI-LB group (Figure 3).
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3.4. Effect of Age and Education on Group Differences
The potential influence of age and education on group differences was assessed given that the
participants with possible and probable MCI-LB were older and less educated compared to the older
control group. This was done by repeating the patient-control comparisons for a subset of control
participants aged over 70 (n = 11), in which age (χ2 (2) = 1.387, p = 0.50) and education (χ2 (2) = 5.980,
p = 0.06) did not significantly differ from the patient groups. The same pattern of results was observed
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for these sub-group comparisons, in which mean RT was significantly lower (χ2 (2) = 11.059, p = 0.004)
and mean accuracy significantly higher in older adults (χ2 (2) = 12.139, p = 0.002) than both patient
groups. Similarly, mean non-decision time was significantly lower in older adults (χ2 (2) = 12.844,
p = 0.002) and boundary separation greater in older adults (χ2 (2) = 6.253, p = 0.044), with no significant
difference in drift rate (χ2 (2) = 0.082, p = 0.960). Thus, age and education did not appear to significantly
affect the differences between patients and older control participants.
3.5. DDM Parameters Are Predicted by Clinical Assessments of Visual Perception
Data from both possible and probable MCI-LB patients were entered into a series of hierarchical
stepwise linear regressions. First, demographic information including education, gender, age, and
MCI-LB group (probable, possible) were entered as predictors of either ACE subscales, NEVHI, CAF,
or DCFS scores. Following this, DDM parameters were added to the models as predictors.
A diagnosis of probable MCI-LB (adj R2 = 0.12, beta = −0.30, p = 0.035) along with years of
education (adj R2 = 0.05, beta = 0.31, p = 0.028) were significant predictors for the ACE visuospatial
score. The addition of DDM parameters to the model revealed that non-decision time (F (3, 45) = 5.413,
R2 = 0.265, adj R2 = 0.129, beta =−0.333, p= 0.014) significantly predicted ACE visuospatial performance
in the patient groups. The addition of non-decision time as a predictor in the model was also significant
(Delta R2 = 0.148, F change (1, 47) = 8.136, p = 0.006).
Moreover, male gender (adj R2 = 0.06, beta = −0.295, =0.036) to significantly predicted NEVHI
score. The addition of DDM parameters to the model showed that non-decision time approached
significance but did not survive corrections for multiple comparisons (adj R2 = 0.062, beta = 0.249,
p = 0.06). Non-decision time was returned as a predictor of DCFS score but did not reach statistical
significance (p = 0.072). Moreover, drift rate was returned as a predictor of CAF score, but did not
reach statistical significance (p = 0.321).
Spearman’s Rho correlational analysis showed that non-decision time was negatively correlated
with ACE Visuo-spatial subscale (rho = −0.38, p < 0.001), but drift rate (p = 0.55) and boundary
separation value (p = 0.92) were not (Figure 4). Mean non-decision time was associated with NEVHI
score but this was not significant after correction for multiple comparisons (p = 0.06). Drift rate (p = 0.32)
and boundary separation value (p = 0.45) did not show a significant relationship with NEVHI score.
Importantly, UPDRS total motor impairment score did not significantly correlate with non-decision
time (p = 0.23). This indicates that non-decision time is more strongly related to perceptual measures,
rather than measures of motor impairments in this instance.
Brain Sci. 2020, 10, x FOR PEER REVIEW 8 of 14 
p = 0.06) did not significantly differ from the patient groups. The same pattern of results was observed 
f r t ese s - r  c parisons, in hich ean RT was significantly lower (χ2 (2) = 11.059, p = 0.004) 
 e  cc r c  si ific tl  i er i  l er a lts (χ2 (2) = . ,  = . ) t  t  tie t 
r s. i il rl , e  - ecision ti e as significantly lower in older adults (χ2 (2) = 12.844, p 
= 0. 02) and boundary separation greater in older a lts (  ( )  . ,   0.044), it   si ific t 
ifference in drift rate (χ2 (2) = 0.082, p = 0.960). Thus, age nd e ucation did not appe r to 
significantly affect the differences between patients and older control participants. 
3.5. DDM Parameters are Predicted by Clinical Assessments of Visual Perception 
Data from both possible and probable MCI-LB patients were entered into a series of hierarchical 
stepwise linear regressions. First, demographic information including education, gender, age, and 
MCI-LB group (probable, possible) were entered as predictors of either ACE subscales, NEVHI, CAF, 
or DCFS scores. Following this, DDM parameters were added to the models as predictors. 
A diagnosis of probable MCI-LB (adj R2 = 0.12, beta = −0.30, p = 0.035) along with years of 
education (adj R2 = 0.05, beta = 0.31, p = 0.028) were significant predictors for the ACE visuospatial 
score. The addition of DDM parameters to the model revealed that non-decision time (F (3, 45) = 5.413, 
R2 = 0.265, adj R2 = 0.129, beta = −0.333, p = 0.014) significantly predicted ACE visuospatial performance 
in the patient groups. The addition of non-decision time as a predictor in the model was also 
significant (Delta R2 = 0.148, F change (1, 47) = 8.136, p = 0.006). 
Moreover, male gender (adj R2 = 0.06, beta = −0.295, =0.036) to significantly predicted NEVHI 
score. The addition of DDM parameters to the model showed that non-decision time approached 
significance but did not survive corrections for multiple comparisons (adj R2 = 0.062, beta = 0.249, p = 
0.06). Non-decision time was returned as a predictor of DCFS score but did not reach statistical 
significance (p = 0.072). Moreover, drift rate was returned as a predictor of CAF score, but did not 
reach statistical significance (p = 0.321). 
Spearman’s Rho correlational analysis showed that non-decision time was negatively correlated 
with ACE Visuo-spatial subscale (rho = −0.38, p < 0.001), but drift rate (p = 0.55) and boundary 
separation value (p = 0.92) were not (Figure 4). Mean non-decision time was associated with NEVHI 
score but this was not significant after correction for multiple comparisons (p = 0.06). Drift rate (p = 
0.32) and boundary separation value (p = 0.45) did not show a significant relationship with NEVHI 
score. Importantly, UPDRS total motor impairment score did not significantly correlate with non-
decision time (p = 0.23). This indicates that non-decision time is more strongly related to perceptual 
measures, rather than measures of motor impairments in this instance. 
 
Figure 4. Non-decision time (t) is negatively related to scores on the Addenbrooke’s Cognitive Exam 
(ACE) Visuospatial subscale in mild cognitive impairment (MCI-LB) groups (adj R2 = 0.129, beta = 
−0.333, p = 0.014). 
Non-dec sion time (t) is negatively r lated t scores on the Addenbrooke’s Cognitive
Exam (ACE) Visuospatial subscale in mild cognitive i pairment (MCI-LB) groups (adj R2 = 0.129,
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3.6. Clinical Measure of Visual Hallucinations Is Related to Non-Decision Time
To further investigate the relationship between visual hallucinations (VH) and drift diffusion
parameters, group comparisons between those patients with a higher NEVHI score (NEVHI+),
and those with a low NEVHI score (NEVHI−) were carried out. There was a significant difference
in non-decision time between the NEVHI+ and NEVHI− group (U = 183, p = 0.024). Boundary
separation (p = 0.416) and drift rate (p = 0.476) did not differ between groups. Finally, Spearman’s
Rho correlation showed a significant positive relationship between NEVHI score and non-decision
time in MCI-LB patients in the NEVHI+ (rho = 5.412, p = 0.013) (Figure 5). However, as the NEVHI
score is not a direct indicator of the presence of visual hallucinations, we also carried out a comparison
between those patients with the presence of complex VH (VH+), as rated by a clinical panel—as per
Donaghy et al. [24]—in accordance with 2017 DLB criteria [41], and patients with absence of complex
VH (VH−). VH+ and VH− patients did not show any significant difference in non-decision time
(p = 0.625) or drift rate (p = 0.659), but VH+ patients had significantly higher boundary separation
values (U = 90, p = 0.002).
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4. Discussion
Our results showed that mean RT were longer in the Lewy body groups than in the controls,
however RT did no differ b tween possible and probable Lewy body groups, tho gh group numbers
were modest. Moreover, accuracy was lower in both Lewy body groups in comparison to controls.
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These findings are consistent with previous reports of lengthened RTs and reduced accuracy in CRT
for Lewy body patients [41,42]. Moreover, previously reported DDM profiles of healthy older adults
were characterized by higher boundary separation values with preserved drift rate and non-decision
times relative to younger adults. Our findings are consistent with previous findings in that drift rate,
and therefore information processing ability, was unaffected by age, while older adults appear to wait
to collate more information about the stimuli to ensure an accurate response [17]. This pattern reflects
a more cautious strategy to decision making.
In addition, we found that MCI-LB patients had longer non-decision times and lower boundary
separation values than healthy older controls but did not differ with regards to drift rate. We propose
that this pattern of results suggests that patients had difficulties at perceptual encoding (non-decision)
stages of decision making. This suggests that, rather than having impaired overall processing,
Lewy body patients have more specific processing deficits in non-decision time, leading to longer
RT. Moreover, patients also experienced shorter boundary separation values, suggesting that they
adopted a less cautious approach than healthy older adults in their decision making in response to
impaired perceptual encoding. This in turn may contribute to lower accuracy. However, no differences
were observed in mean drift rates, although it is worthwhile mentioning that patients as a group
exhibited increased variability in all DDM parameters. Thus, despite the null effect for mean drift rates,
MCI-LB patients drift rate values were more heterogenous, suggesting that perceptual encoding and
shorter boundary separation values also affected the rate of information accumulation and hence the
quality of the decision-making process. Previous findings in hallucinating PD patients have reported
lower drift rates, which indicated less effective sensory accumulation of evidence [19]. Here we did
not find any differences in mean but in the variance of the drift rate which suggests that MCI-LB
was associated with a greater variability of evidence accumulation. This may mean that MCI-LB
patients experienced fluctuations in their ability to effectively process information, in part as a result of
perceptual encoding problems, or in part as a result of impairments in alerting and focusing attention.
Greater trial-to-trial variability in drift rates would result in slower RT and reduced accuracy, therefore
investigating this further may be valuable in future research. As we employed a simple drift diffusion
model due to limited trial numbers, this is difficult to recover, therefore future investigations should
employ more complex models to examine the relationship between trial-by-trial variability in drift
rates and fluctuation in attention. In addition, correlations between DDM variance and cognitive
fluctuations may also be of interest, given the transient and variable nature of cognition in MCI-LB and
DLB. Moreover, this may further illustrate the variability of cognitive impairment, and its relationship
with subsequent clinical presentation in mild cognitive impairment stages of DLB [7].
Approximately 80% of DLB patients experience visual hallucinations [23] that are known to be
related to impairments in visuospatial performance (Hamilton et al., 2012). Consistent with a previous
study in PD [19] we observed differences between MCI-LB and control groups in non-decision time,
a parameter that reflects both perceptual encoding and motor aspects. However, in contrast to the
MCI-LB patients in the present study, PD patients had shorter, not longer, non-decision times in
comparison to older adults [19]. As non-decision time is comprised of both perceptual and motor
aspects, the authors proposed that shorter non-decision times may be partly due to impulsivity-related
reductions in response latencies in PD. In the present study, non-decision times were not related to
motor impairments, as measured by UPDRS score, but did relate to ACE visuospatial scores, suggesting
that differences in MCI-LB patients were most likely due to impaired perceptual encoding. Together,
these results suggest that, while the precise mechanisms may differ, both PD and MCI-LB patients
experience perceptual encoding impairment that make sensory evidence less informative to them.
The results from our hierarchical stepwise regression fitting revealed that mean non-decision
values predicted visuo-spatial performance but not NEVHI score. However, further analyses showed
that patients in the NEVHI+ had longer non-decision times than NEVHI− and non-decision time
correlated positively with higher NEVHI score in this group. As a positive NEVHI score does not
necessarily reflect the incidence of visual hallucinations but can be due to other visual problems [43],
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we also classified patients on the basis of clinical ratings into those with a history of visual hallucinations
and those without. This comparison revealed that individuals with visual hallucinations showed wider
boundary separation than those without. Our finding of significantly longer non-decision times in the
NEVHI+ versus the NEVHI− group suggests that patients who experience visual difficulties including
visual hallucinations are prone to difficulties in perceptual encoding and that these encoding problems
may contribute to their experience of visual hallucinations. The additional finding that individuals
with a history of visual hallucinations showed larger boundary separation than those without, suggests
that these individuals experience additional decision-making problems and adopt a more cautious
response strategy in light of noisy perceptual input, that may contribute to and/or reflect the experience
of visual hallucinations. Thus, perceptual encoding difficulties appear to be a necessary but not a
sufficient condition for the occurrence of visual hallucinations. Such an interpretation is consistent with
current theories of visual hallucinations in DLB [21,22] proposing that hallucinations occur as a product
of impaired perceptual encoding or bottom-up processing, and subsequent over activation of top
down processes, which may result in incorrect objects being inserted into the visual scene, i.e., visual
hallucinations. In this context, our results may demonstrate that the processing of sensory stimuli is
slower and potentially less informative in all MCI-LB patients but that in patients who hallucinate
such impaired sensory processing is accompanied by additional top-down decision-making problems.
In contrast to our findings, O’Callaghan et al. [19] reported that all PD patients showed wider
decision boundaries, but only hallucinating patients showed slower drift rates than those patients who
did not hallucinate. While this pattern of results also supports the view that impaired sensory evidence
accumulation may lead to reduced information processing quality and an over-reliance on top down
processing in PD, which in turn may underpin visual hallucinations, the mechanisms leading to these
impairments seem to differ between PD and MCI-LB.
There were limitations of the present study. Due to practicalities in recruitment, healthy control
participants were significantly younger on average than probable and possible Lewy body patients,
which may have affected some drift diffusion estimates. However, age was not a significant
predictor in the linear regression analyses. In addition, due to recruitment from a University panel,
control participants had significantly more years of education than Lewy body groups, which may also
have influenced performance in some cognitive tests. We assessed the potential influence of age and
education on our results by comparing patients with a subgroup of controls that were closely matched
for these variables. These additional analyses resulted in the same pattern of results, suggesting that
the group differences in age and education did not drive our findings.
Moreover, although tasks were similar in nature between healthy control and patient groups,
there were some notable differences in both trial number and stimuli which could influence RT and
accuracy and bias the DDM modelling. Firstly, trial numbers were relatively low in the CRT in MCI-LB
groups, due to practical limitations and patients’ task completion ability, which may influence the
accuracy of model fitting. Secondly, there is possibility that the presence of neutral flankers in the
healthy control task may produce lower drift rates due to crowding effects, therefore resulting in
an under estimation of the current group differences in our results. Thirdly, as control participants
also took part in randomly presented congruent and incongruent trials, boundary separation may be
raised as older adults become more cautious in response overall, thus overestimating the boundary
separation effect in this study [44]. Finally, non-decision time may be influenced by a more complex
stimuli, resulting in an under-estimation of the observed perceptual encoding group differences in
the present study. This does pose some limitation to the conclusions which can be drawn, therefore
replication in a larger sample, and with identical task conditions is vital to clarify these effects. Despite
this, employing the same task between patients and control subjects is also challenging, as those tasks
which are accessible for patients in terms of trial number or stimuli may be very simple for controls to
complete, resulting in a ceiling effect, and vice versa.
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To conclude, the present findings suggest that impaired perceptual encoding, as estimated by the
DDM, contributes to NEVHI score in MCI-LB, and altered boundary separation may be related to the
presence of visual hallucinations [19,45].
Author Contributions: Conceptualization, L.R. and C.M.-B.; Data curation, P.C.D.; Formal analysis, L.R.;
Resources, C.A.H., P.C.D., and A.T.; Supervision, C.M.-B.; Writing—original draft, L.R.; Writing—review and
editing, C.A.H., J.C., P.C.D., A.T., and C.M.-B. All authors have read and agreed to the published version of
the manuscript.
Funding: LR is supported by a School of Psychology Open PhD scholarship. This research was supported by the
NIHR Newcastle Biomedical Research Centre (grant numbers BH120812 and BH120878).
Acknowledgments: We gratefully acknowledge colleagues at Newcastle University involved in the LewyPro
study for provision of patient data. The authors would also like to acknowledge Craig Hedge for his generous
provision of EZ scripts, and his insightful help and comments.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. McKeith, I.G.; Boeve, B.F.; Dickson, D.W.; Halliday, G.; Taylor, J.-P.; Weintraub, D.; Aarsland, D.; Galvin, J.;
Attems, J.; Ballard, C.G.; et al. Diagnosis and management of dementia with Lewy bodies: Fourth consensus
report of the DLB Consortium. Neurology 2017, 89, 88–100. [CrossRef]
2. Metzler-Baddeley, C. A Review of Cognitive Impairments in Dementia with Lewy Bodies Relative to
Alzheimer’s Disease and Parkinson’s Disease with Dementia. Cortex 2007, 43, 583–600. [CrossRef]
3. Ciafone, J.; Little, B.; Thomas, A.J.; Gallagher, P. The Neuropsychological Profile of Mild Cognitive Impairment
in Lewy Body Dementias. J. Int. Neuropsychol. Soc. 2020, 26, 210–225. [CrossRef] [PubMed]
4. Collerton, D.; Burn, D.; McKeith, I.; O’Brien, J. Systematic Review and Meta-Analysis Show that Dementia
with Lewy Bodies Is a Visual-Perceptual and Attentional-Executive Dementia. Dement. Geriatr. Cogn. Disord.
2003, 16, 229–237. [CrossRef] [PubMed]
5. Bowman, A.; Bruce, V.; Colbourn, C.J.; Collerton, D. Compensatory shifts in visual perception are associated
with hallucinations in Lewy body disorders. Cogn. Res. Princ. Implic. 2017, 2, 26. [CrossRef] [PubMed]
6. Taylor, J.-P.; Colloby, S.J.; McKeith, I.G.; O’Brien, J.T. Covariant perfusion patterns provide clues to the origin
of cognitive fluctuations and attentional dysfunction in Dementia with Lewy bodies. Int. Psychogeriatr. 2013,
25, 1917–1928. [CrossRef]
7. McKeith, I.G.; Ferman, T.J.; Thomas, A.J.; Blanc, F.; Boeve, B.F.; Fujishiro, H.; Kantarci, K.; Muscio, C.;
O’Brien, J.; Postuma, R.B.; et al. Research criteria for the diagnosis of prodromal dementia with Lewy bodies.
Neurology 2020, 94, 743–755. [CrossRef] [PubMed]
8. Gauthier, S.; Reisberg, B.; Zaudig, M.; Petersen, R.C.; Ritchie, K.; Broich, K.; Belleville, S.; Brodaty, H.;
Bennett, D.; Chertkow, H.; et al. Mild cognitive impairment. Lancet 2006, 367, 1262–1270. [CrossRef]
9. Ballard, C.; O’Brien, J.; Morris, C.M.; Barber, R.; Swann, A.; Neill, D.; McKeith, I. The progression of cognitive
impairment in dementia with Lewy bodies, vascular dementia and Alzheimer’s disease. Int. J. Geriatr. Psychiatry
2001, 16, 499–503. [CrossRef]
10. Bradshaw, J. Fluctuating cognition in dementia with Lewy bodies and Alzheimer’s disease is qualitatively
distinct. J. Neurol. Neurosurg. Psychiatry 2004, 75, 382–387. [CrossRef]
11. Fuentes, L.J.; Fernández, P.J.; Campoy, G.; Antequera, M.M.; García-Sevilla, J.; Antúnez, C. Attention
Network Functioning in Patients with Dementia with Lewy Bodies and Alzheimer’s Disease. Dement. Geriatr.
Cogn. Disord. 2010, 29, 139–145. [CrossRef] [PubMed]
12. Bailon, O.; Roussel, M.; Boucart, M.; Krystkowiak, P.; Godefroy, O. Psychomotor Slowing in Mild
Cognitive Impairment, Alzheimer’s Disease and Lewy Body Dementia: Mechanisms and Diagnostic
Value. Dement. Geriatr. Cogn. Disord. 2010, 29, 388–396. [CrossRef] [PubMed]
13. Cormack, F.; Gray, A.; Ballard, C.; Tovée, M.J. A failure of‘Pop-Out’ in visual search tasks in dementia with
Lewy Bodies as compared to Alzheimer’s and Parkinson’s disease. Int. J. Geriatr. Psychiatry 2004, 19, 763–772.
[CrossRef] [PubMed]
14. Ratcliff, R. A theory of memory retrieval. Psychol. Rev. 1978, 85, 59–108. [CrossRef]
15. Ratcliff, R.; Rouder, J.N. Modeling Response Times for Two-Choice Decisions. Psychol. Sci. 1998, 9, 347–356.
[CrossRef]
Brain Sci. 2020, 10, 540 13 of 14
16. Wiecki, T.V.; Sofer, I.; Frank, M.J. HDDM: Hierarchical Bayesian estimation of the Drift-Diffusion Model in
Python. Front. Neuroinform. 2013, 7, 14. [CrossRef]
17. Ratcliff, R. Modeling response signal and response time data. Cogn. Psychol. 2006, 53, 195–237. [CrossRef]
18. Spaniol, J.; Madden, D.J.; Voss, A. A Diffusion Model Analysis of Adult Age Differences in Episodic and
Semantic Long-Term Memory Retrieval. J. Exp. Psychol. Learn. Mem. Cogn. 2006, 32, 101–117. [CrossRef]
19. O’Callaghan, C.; Hall, J.M.; Tomassini, A.; Muller, A.J.; Walpola, I.C.; Moustafa, A.A.; Shine, J.M.; Simon, J.G.L.
Visual Hallucinations Are Characterized by Impaired Sensory Evidence Accumulation: Insights from
Hierarchical Drift Diffusion Modeling in Parkinson’s Disease. Biol. Psychiatry Cogn. Neurosci. Neuroimaging
2017, 2, 680–688.
20. Wagenmakers, E.-J.; Van Der Maas, H.L.J.; Grasman, R.P.P.P. An EZ-diffusion model for response time and
accuracy. Psychon. Bull. Rev. 2007, 14, 3–22. [CrossRef]
21. Collerton, D.; Perry, E.; McKeith, I. Why people see things that are not there: A novel Perception and
Attention Deficit model for recurrent complex visual hallucinations. Behav. Brain Sci. 2005, 28, 737–757.
[CrossRef] [PubMed]
22. Shine, J.M.; Halliday, G.M.; Naismith, S.L.; Lewis, S.J.G. Visual misperceptions and hallucinations in
Parkinson’s disease: Dysfunction of attentional control networks? Mov. Disord. 2011, 26, 2154–2159.
[CrossRef] [PubMed]
23. Onofrj, M.; Taylor, J.P.; Monaco, D.; Franciotti, R.; Anzellotti, F.; Bonanni, L.; Onofrj, V.; Thomas, A. Visual
Hallucinations in PD and Lewy Body Dementias: Old and New Hypotheses. Behav. Neurol. 2013, 27, 479–493.
[CrossRef] [PubMed]
24. Donaghy, P.C.; Taylor, J.-P.; O’Brien, J.; Barnett, N.; Olsen, K.; Colloby, S.J.; Lloyd, J.; Petrides, G.; McKeith, L.G.;
Thomas, A.J. Neuropsychiatric symptoms and cognitive profile in mild cognitive impairment with Lewy
bodies. Psychol. Med. 2018, 48, 2384–2390. [CrossRef] [PubMed]
25. Thomas, A.J.; Donaghy, P.C.; Roberts, G.; Colloby, S.J.; Barnett, N.A.; Petrides, G.; Lloyd, J.; Olsen, K.;
Taylor, J.-P.; McKeith, L.G.; et al. Diagnostic accuracy of dopaminergic imaging in prodromal dementia with
Lewy bodies. Psychol. Med. 2019, 49, 396–402. [CrossRef] [PubMed]
26. Mioshi, E.; Dawson, K.; Mitchell, J.; Arnold, R.; Hodges, J.R. The Addenbrooke’s Cognitive Examination
Revised (ACE-R): A brief cognitive test battery for dementia screening. Int. J. Geriatr. Psychiatry 2006,
21, 1078–1085. [CrossRef]
27. Warrington, E.K.; McKenna, P. Graded Naming Test: Manual; Cambridge Cognition Ltd.: Bottisham, UK, 1983.
28. Rey, A. [The Clinical Examination in Psychology]; Presses Universitaries De France: Oxford, UK, 1958; 222p.
(L’examen Clinique en Psychologie).
29. Yesavage, J.A. Geriatric Depression Scale. Psychopharmacol. Bull. 1988, 24, 709–711.
30. Walker, M.P.; Ayre, G.; Perry, E.; Wesnes, K.A.; McKeith, L.G.; Tovée, M.J.; Edwardson, J.; Ballard, C.
Quantification and Characterisation of Fluctuating Cognition in Dementia with Lewy Bodies and Alzheimer’s
Disease. Dement. Geriatr. Cogn. Disord. 2000, 11, 327–335. [CrossRef]
31. Lee, D.R.; McKeith, I.G.; Mosimann, U.P.; Ghosh-Nodial, A.; Grayson, L.; Wilson, B.; Thomas, A.J.
The Dementia Cognitive Fluctuation Scale, a New Psychometric Test for Clinicians to Identify Cognitive
Fluctuations in People with Dementia. Am. J. Geriatr. Psychiatry 2014, 22, 926–935. [CrossRef]
32. Cummings, J.L.; Mega, M.; Gray, K.; Rosenberg-Thompson, S.; Carusi, D.A.; Gornbein, J. The Neuropsychiatric
Inventory: Comprehensive assessment of psychopathology in dementia. Neurology 1994, 44, 2308. [CrossRef]
33. Mosimann, U.P.; Collerton, D.; Dudley, R.; Meyer, T.D.; Graham, G.; Dean, J.L.; Bearn, D.; Killen, A.;
Dickinson, L.; Clarke, M.P.; et al. A semi-structured interview to assess visual hallucinations in older people.
Int. J. Geriatr. Psychiatry 2008, 23, 712–718. [CrossRef] [PubMed]
34. Goetz, C.G.; Fahn, S.; Martínez-Martín, P.; Poewe, W.; Sampaio, C.; Stebbins, G.T.; Stern, M.B.; Tilley, B.C.;
Dodel, R.; Dubois, B.; et al. Movement Disorder Society-sponsored revision of the Unified Parkinson’s
Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan. Mov. Disord. 2007,
22, 41–47. [CrossRef] [PubMed]
35. Lawton, M.P.; Brody, E.M. Assessment of Older People: Self-Maintaining and Instrumental Activities of
Daily Living. Gerontologist 1969, 9, 179–186. [CrossRef] [PubMed]
36. Eriksen, B.A.; Eriksen, C.W. Effects of noise letters upon the identification of a target letter in a nonsearch
task. Percept. Psychophys. 1974, 16, 143–149. [CrossRef]
Brain Sci. 2020, 10, 540 14 of 14
37. van Ravenzwaaij, D.; Oberauer, K. How to use the diffusion model: Parameter recovery of three methods:
EZ, fast-dm, and DMAT. J. Math. Psychol. 2009, 53, 463–473. [CrossRef]
38. Ratcliff, R.; McKoon, G. The Diffusion Decision Model: Theory and Data for Two-Choice Decision Tasks.
Neural Comput. 2008, 20, 873–922. [CrossRef] [PubMed]
39. Ratcliff, R.; Childers, R. Individual Differences and Fitting Methods for the Two-Choice Diffusion Model
of Decision Making. Decision (Wash.). 2015. Available online: https://www.ncbi.nlm.nih.gov/pmc/articles/
PMC4517692/ (accessed on 13 May 2020).
40. Benjamini, Y.; Hochberg, Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to
Multiple Testing. J. R. Stat. Soc. Ser. B (Methodol.) 1995, 57, 289–300. [CrossRef]
41. Firbank, M.; Kobeleva, X.; Cherry, G.; Killen, A.; Gallagher, P.; Burn, D.J.; Thomas, A.J.; O’Brien, J.; Taylor, J.-P.
Neural correlates of attention-executive dysfunction in lewy body dementia and Alzheimer’s disease: Neural
Correlates of Attention in Dementia. Hum. Brain Mapp. 2015, 37, 1254–1270. [CrossRef]
42. Firbank, M.J.; Parikh, J.; Murphy, N.; Killen, A.; Allan, C.L.; Collerton, D.; Blamire, A.; Taylor, J.-P. Reduced
occipital GABA in Parkinson disease with visual hallucinations. Neurology 2018, 91, e675–e685. [CrossRef]
43. Holiday, K.A.; Pirogovsky-Turk, E.; Malcarne, V.L.; Filoteo, J.V.; Litvan, I.; Lessig, S.L.; Song, D.; Schiehser, D.M.
Psychometric Properties and Characteristics of the North-East Visual Hallucinations Interview in Parkinson’s
Disease. Mov. Disord. Clin. Pract. 2017, 4, 717–723. [CrossRef]
44. Hedge, C.; Powell, G.; Sumner, P. The mapping between transformed reaction time costs and models of
processing in aging and cognition. Psychol. Aging 2018, 33, 1093. [CrossRef] [PubMed]
45. Diederich, N.J.; Goetz, C.G.; Stebbins, G.T. Repeated visual hallucinations in Parkinson’s disease as disturbed
external/internal perceptions: Focused review and a new integrative model. Mov. Disord. 2005, 20, 130–140.
[CrossRef] [PubMed]
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
